← Back to headlines
Intellia Therapeutics Beats Q4 Earnings and Revenue Estimates
Intellia Therapeutics reported a GAAP EPS of -$0.83, beating estimates by $0.12, and revenue of $23.02 million, significantly surpassing expectations by $10.85 million.
26 Feb, 12:34 — 26 Feb, 12:34
ℹOnly 1 source covers this story
